ArticleThe Journal of infectious diseases2013

A heterologous prime/boost vaccination strategy enhances the immunogenicity of therapeutic vaccines for hepatitis C virus.

Anne Fournillier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.